1123695--4/14/2010--IMARX_THERAPEUTICS

related topics

{stock, price, operating}

{interest, director, officer}

{stock, price, share}

{provision, law, control}

{control, financial, internal}

{regulation, change, law}

{acquisition, growth, future}

If the Merger Agreement and the Stock Purchase Agreement transactions with Sycamore Films close there is no assurance that the new company management will be successful in implementing their business strategy. We will continue to incur the expenses of complying with public company reporting requirements, which may be economically burdensome. We have no employees. We have entered into consulting relationships. We may not have sufficient personnel to effectively consummate a strategic transaction or to orderly wind down the operations of the Company. Failure of our internal control over financial reporting could harm our business and financial results. We intend to issue approximately 79,376,735 shares of our common stock to the Sycamore Films shareholders including the former shareholders of Sweet Spot. As a result, Sycamore Films will become a wholly-owned subsidiary of ImaRx and the former shareholders of Sycamore Films will hold in the aggregate approximately eighty-six percent (86%) of our outstanding shares of common stock on a fully diluted basis. which will result in substantial dilution to our existing stockholders. We cannot assure you that following the strategic transaction with Sycamore Films, our common stock will be listed on NASDAQ or any other securities exchange. Risks Related to Our Common Stock Our principal stockholders and management own a significant percentage of our stock and will be able to exercise significant influence over our affairs. If our stock price is volatile, purchasers of our common stock could incur substantial losses. We are at risk of securities class action litigation due to our stock price volatility. If there are substantial sales of common stock, our stock price could decline.

Full 10-K form ▸

1123695--4/14/2010--IMARX_THERAPEUTICS_INC